NASDAQ: SGMTSagimet Biosciences Inc Stock Ownership - Who owns Sagimet Biosciences?
Insider buying vs selling
Have Sagimet Biosciences Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| David Happel | President CEO | 2025-07-21 | 65,478 | $9.14 | $598.14kSell |
| Eduardo Bruno Martins | Chief Medical Officer | 2025-07-21 | 8,277 | $9.14 | $75.61kSell |
| Elizabeth Rozek | General Counsel and CCO | 2025-07-21 | 10,780 | $9.14 | $98.48kSell |
SGMT insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when SGMT insiders and whales buy or sell their stock.
SGMT Shareholders
What type of owners hold Sagimet Biosciences Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Patrick J. Kerins | 9.27% | 3,013,414 | $20.37M | Insider |
| Forest Baskett | 9.26% | 3,011,575 | $20.36M | Insider |
| Scott D. Sandell | 9.25% | 3,007,272 | $20.33M | Insider |
| Nea Partners 13 Limited Partnership | 9.23% | 3,000,275 | $20.28M | Insider |
| New Enterprise Associates 13 LP | 9.23% | 3,000,275 | $20.28M | Insider |
| Woodline Partners LP | 7.85% | 2,552,536 | $17.26M | Institution |
| Beth C. Seidenberg | 6.25% | 2,031,118 | $13.73M | Insider |
| Kpcb Pbd Associates LLC | 5.84% | 1,899,475 | $12.84M | Insider |
| Jinzi Jason Wu | 5.09% | 1,654,701 | $11.19M | Insider |
| Blue Owl Capital Holdings LP | 4.08% | 1,328,351 | $8.98M | Institution |
SGMT vs Biotech Stocks
Sagimet Biosciences Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.